Beauty Health CEO Andrew Stanleick departs; director Marla Beck named interim CEO

SkinHealth Systems Inc.

Andrew Stanleick steps down as CEO and board member effective Nov 19, 2023; will advise through Dec 31, 2023.
Director Marla Beck appointed interim CEO from Nov 20, 2023, for a 6-month term; resigns from audit committee.
Beck co-founded Bluemercury; led it as CEO for 22 years including post-acquisition by Macy's.
Interim CEO compensation: $200K monthly base (min. 4 months), $500K RSUs ratably vesting over term, $400K change-in-control bonus.
Board has initiated a formal search for a permanent CEO; Saunders expresses confidence in strategy and long-term growth.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Andrew Stanleick

chief executive officer

SKIN · SkinHealth Systems Inc.

Effective: 2023-11-19
Successor: Marla Beck
Filed: November 13, 2023, 6:59 PM ET

Andrew Stanleick, who will step down from the role of chief executive officer of the Company, effective as of November 19, 2023.

Appointed (interim)

Marla Beck

interim chief executive officer

SKIN · SkinHealth Systems Inc.

Effective: 2023-11-20
Filed: November 13, 2023, 6:59 PM ET

the Board of Directors (the “Board”) of The Beauty Health Company (the “Company”) appointed Marla Beck, age 53, as interim chief executive officer of the Company (the “Interim CEO”), for a 6-month term (the “Term”) effective November 20, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Andrew Stanleick departed as chief executive officer at SkinHealth Systems Inc..

Action: step down
Role: chief executive officer

Exact text from the filing

Andrew Stanleick, who will step down from the role of chief executive officer of the Company, effective as of November 19, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Marla Beck was appointed as interim chief executive officer at SkinHealth Systems Inc..

Action: appointed
Role: interim chief executive officer

Exact text from the filing

the Board of Directors (the “Board”) of The Beauty Health Company (the “Company”) appointed Marla Beck, age 53, as interim chief executive officer of the Company (the “Interim CEO”), for a 6-month term (the “Term”) effective November 20, 2023

View on SEC.gov

SkinHealth Systems Inc. filing history →

Source: SEC EDGAR

accession 0001628280-23-038598

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.